The regulatory pathway and commercial readiness require different expertise, but they are not independent on the road to the US market. This checklist helps connect requirements verified by qualified regulatory specialists to commercial decisions.
1. Document product and market assumptions
Bring target patient or customer segments, competition, differentiation assumptions and commercial implications of the pathway into one decision document.
2. Identify critical dependencies
Make visible which manufacturing, supply, labeling, channel, data and partner decisions depend on verified regulatory milestones.
- Assign an owner to each dependency.
- Record assumptions and validation sources.
- Model delays that may affect launch.
- Refresh readiness status regularly.
3. Make commercial readiness measurable
Do not leave “ready” as a general opinion. Establish measurable acceptance criteria for channels, teams, data, reporting and partners.
Kaynaklar / Sources
- FDA — How Drugs are Developed and Approved
- FDA — Abbreviated New Drug Application (ANDA)
- FDA — Orange Book
This article is for general information and is not legal, regulatory or medical advice. Confirm product-specific requirements with qualified specialists and the relevant authorities.
